Results 121 to 130 of about 280,167 (140)

Nursing student training as a novel approach to increasing community-based access to contraception in the Democratic Republic of the Congo: evaluation of outcomes. [PDF]

open access: yesHealth Policy Plan
Akilimali P   +12 more
europepmc   +1 more source

Serum norethisterone (NET) levels in NET-enanthate (NET-EN) injectable contraception users substantially interfere with testosterone immunoassay measurements and confound interpretation of biological outcomes. [PDF]

open access: yesContracept Reprod Med
Avenant C   +10 more
europepmc   +1 more source

Capacity-Building Through Digital Approaches: Evaluating the Feasibility and Effectiveness of eLearning to Introduce Subcutaneous DMPA Self-Injection in Senegal and Uganda. [PDF]

open access: yesGlob Health Sci Pract
Wood S   +9 more
europepmc   +1 more source

Would you be interested in DMPA-SC? An implementation project in two urban primary care clinics.

Contraception, 2022
Self-administered DMPA-SC has similar efficacy to DMPA-IM with potential benefits. We conducted an implementation study to assess interest in and successful use of DMPA-SC for patients using DMPA-IM. Four physicians telephoned patients with DMPA-IM on their medication list in two urban primary care clinics and offered counseling and prescriptions to ...
Christina Miles   +3 more
semanticscholar   +3 more sources

Acceptability of Contraceptive Self-Injection with DMPA-SC Among Adolescents in Gulu District, Uganda.

International Perspectives on Sexual and Reproductive Health, 2017
In Uganda, an estimated one in four adolescent women have begun childbearing. Many adolescent pregnancies are unintended because of substantial barriers to contraceptive access. The injectable contraceptive is the most commonly used method in Uganda, and a new subcutaneous version offers the possibility of reducing access barriers by offering a self ...
Jane Cover   +5 more
semanticscholar   +3 more sources

Contraceptive efficacy and safety of DMPA-SC

Contraception, 2004
DMPA-SC 104 mg/0.65 mL is a new, low-dose subcutaneous (SC) formulation of Depo-Provera contraceptive injection (150 mg/mL medroxyprogesterone acetate injectable suspension) that provides efficacy, safety and immediacy of onset equivalent to Depo-Provera intramuscular (IM) injection.
J, Jain   +4 more
openaire   +2 more sources

Effect of subcutaneous depo-medroxyprogesterone acetate (DMPA-SC) on serum androgen markers in normal-weight, obese, and extremely obese women

Contraception, 2012
The effects of subcutaneous depo-medroxyprogesterone acetate (DMPA-SC) injection on androgenic markers in obese women have not previously been studied.Five normal-weight [body mass index (BMI)=18.5-24.9 kg/m²], five obese (BMI=30-39.9 kg/m²) and five extremely obese (BMI≥40 kg/m²) women were recruited for this prospective experimental study in which ...
Penina, Segall-Gutierrez   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy